Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Equities research analysts expect Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Rating) to post $6.40 million in sales for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Xenon Pharmaceuticals’ earnings. The highest sales estimate is $14.20 million and the lowest is $1.00 million. Xenon Pharmaceuticals reported sales of $2.22 million during […]
Brokerages predict that Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Rating) will post ($0.47) earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Xenon Pharmaceuticals’ earnings. The lowest EPS estimate is ($0.52) and the highest is ($0.34). Xenon Pharmaceuticals reported earnings per share of ($0.51) during […]
Brown Advisory Inc. acquired a new position in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 12,911 shares of the biopharmaceutical company’s stock, valued at approximately $403,000. Other hedge […]